Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,026.50
+11.00 (0.18%)
Sep 12, 2025, 3:29 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.60 trillion as of September 12, 2025. Its market cap has increased by 22.93% in one year.
Market Cap
1.60T
Enterprise Value
1.56T
Revenue
96.52B
Ranking
n/a
PE Ratio
69.42
Stock Price
6,026.50
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.60T, an increase of 78,496.60%. That is a compound annual growth rate of 34.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1,599.85B | -1.19% |
| Dec 31, 2024 | 1,619.04B | 56.22% |
| Dec 29, 2023 | 1,036.36B | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1,241.92B | 21.77% |
| Dec 31, 2020 | 1,019.90B | 108.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,878.76B |
| Cipla | 1,271.89B |
| Apollo Hospitals Enterprise | 1,132.23B |
| Mankind Pharma | 1,064.75B |
| Zydus Lifesciences | 1,051.26B |
| Fortis Healthcare | 732.31B |
| Alkem Laboratories | 651.39B |
| Aurobindo Pharma | 635.63B |